← Back to Patent Explorer
US4833125A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of increasing bone mass

Assignee: General Hospital Corp
•
Filing: 1987-05-21
•
Granted: 1989-05-23
•
Expires: 2007-05-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for increasing bone mass in a human afflicted with osteoporosis or a similar disease which comprises administering to the human so afflicated an effective amount of a composition comprising a parathyroid hormone or physiologically active fragment thereof, or equivalents thereof, in combination with either (a) a hydroxylated Vitamin D compound, or a structural or functional analogue thereof, or (b) a dietary calcium supplement. Pharmaceutical compositions containing the necessary components are also disclosed.

Inventors

  • 👤 Robert M. Neer
  • 👤 John T. Potts, Jr.
  • 👤 David M. Slovik

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 06:46
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/29

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 96 words
A kit useful for administering a bone mass increasing composition comprising a carrier being compartmentalized to receive in close confinement therein one or more containers wherein: (a) a first container or series of containers contain parathyoid hormone or a physiologically active fragment thereof; said hormone or said fragment obtainable from a human, or other animal; (b) a second container contains an agent selected from the group consisting of: (i) a hydroxylated Vitamin D compound, and (ii) a dietary calcium supplement, and (c) a third container contains a buffer for reconstituting or diluting components of said kit.
Claim 2
Dependent Claim 96 words
A kit useful for administering a bone mass increasing composition comprising a carrier being compartmentalized to receive in close confinement therein one or more containers wherein: (a) a first container or series of containers contain parathyoid hormone or a physiologically active fragment thereof; said hormone or said fragment obtainable from a human, or other animal; (b) a second container contains an agent selected from the group consisting of: (i) a hydroxylated Vitamin D compound, and (ii) a dietary calcium supplement, and (c) a third container contains a buffer for reconstituting or diluting components of said kit.
Claim 3
Dependent Claim 19 words
The kit of claim 1 wherein said kit contains means for administering said first agent and said second agent.
Claim 4
Dependent Claim 16 words
The kit of claim 1 wherein said first container contains a peptide fragment of parathyroid hormone.
Claim 5
Dependent Claim 24 words
The kit of claim 3 wherein said peptide fragment consists of the first 34 amino acid residues from the amino terminal of parathyroid hormone.
Claim 6
Dependent Claim 15 words
The kit of claim 1 wherein said synergistic agent is a hydroxylated Vitamin, D compound.
Claim 7
Dependent Claim 12 words
The kit of claim 5 wherein said compound is 1-hydroxy Vitamin D.
Claim 8
Dependent Claim 13 words
The kit of claim 5 wherein said compound is 1, 25-dihydroxy Vitamin D.
Claim 9
Dependent Claim 14 words
The kit of claim 1 wherein said synergistic agent is a dietary calcium supplement.

References Cited (Backward Citations)

US4698328A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-05-22 1992-11-21 1993-05-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-05-22 1996-11-21 1997-05-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-05-22 2000-11-21 2001-05-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag